Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2016-10-13

Clinical Trial Update: SARC021C: A Continuation Study of TH-CR-406/SARC021

View source ↗

Summary

This document provides a continuation study update (SARC021C) for TH-CR-406/SARC021 in soft tissue sarcoma. The study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TH-CR-406/SARC021

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Soft Tissue Sarcoma | Status: NO_LONGER_AVAILABLE